Denali Therapeutics (DNLI) Current Deferred Revenue (2018 - 2022)
Denali Therapeutics (DNLI) reported Current Deferred Revenue of $290.05 million for Q4 2022, up 939.1% from $27.92 million a year earlier.
Powered by 
Analysis
Denali Therapeutics (DNLI) Current Deferred Revenue (2018 - 2022) Analysis & Trends
Dating back to Q1 2018, Denali Therapeutics' Current Deferred Revenue record includes 18 quarters.
- Current Deferred Revenue has increased for four consecutive years, with a four-year compound annual growth rate of 124.5% (FY2018 to FY2022).
- By year, Current Deferred Revenue came in at $27.92 million in FY2021 (+40.2%), $19.91 million in FY2020 (+6.3%), $18.74 million in FY2019 (+64.0%) and $11.43 million in FY2018.
- The Q4 2022 figure ranks as the highest quarterly Current Deferred Revenue in data going back to Q1 2018.
- Year over year, Current Deferred Revenue gained in two of the last six quarters, with growth averaging 109.1%.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2022 (growth of 939.1%); the low point was Q3 2022 (a decline of 98.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Denali Therapeutics | 3.32 Bn | 3.32 Bn | 3.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 290.05 Mn |
| Sep 30, 2022 | 23,000.00 |
| Dec 31, 2021 | 27.92 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 5.76 Mn |
| Mar 31, 2021 | 12.89 Mn |
| Dec 31, 2020 | 19.91 Mn |
| Sep 30, 2020 | 28.02 Mn |
| Jun 30, 2020 | 34.13 Mn |
| Mar 31, 2020 | 24.67 Mn |
| Dec 31, 2019 | 18.74 Mn |
| Sep 30, 2019 | 18.19 Mn |
| Jun 30, 2019 | 22.60 Mn |
| Mar 31, 2019 | 23.15 Mn |
| Dec 31, 2018 | 11.43 Mn |
| Sep 30, 2018 | 12.66 Mn |
| Jun 30, 2018 | 8.72 Mn |
| Mar 31, 2018 | 8.43 Mn |
API Access
Denali Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();